Literature DB >> 23204165

Glycerol-3-phosphate dehydrogenase 2 is a novel factor H-, factor H-like protein 1-, and plasminogen-binding surface protein of Candida albicans.

Shanshan Luo1, Ralf Hoffmann, Christine Skerka, Peter F Zipfel.   

Abstract

Candida albicans uses human complement regulators such as factor H and factor H-like protein 1 (FHL-1) for immune evasion. To define the whole panel of fungal complement-evasion molecules, C. albicans cell extract was absorbed to a factor H-coupled matrix. One 52-kDa protein was eluted and identified by mass spectrometry as glycerol-3-phosphate dehydrogenase 2 (Gpd2). Consequently, Gpd2 was recombinantly expressed and purified. Recombinant Gpd2 binds factor Hand and FHL-1, mainly via short consensus repeat 7; and binds plasminogen, via lysine residues. The 3 human complement regulators, when attached to candida Gpd2, became functionally active, and the attached host proteins assist in inactivation of the complement cascade or cleave fibrinogen in the extracellular matrix component fibrinogen. Polyclonal Gpd2 antiserum was generated and localized Gpd2 at the surface of C. albicans. In addition, candida Gpd2 bound to human nonphagocytic cells but not to phagocytic U937 cells. Thus, candida Gpd2 is a novel fungal immune evasion protein that binds several human complement regulators and, in addition, binds human cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204165     DOI: 10.1093/infdis/jis718

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Simple polysaccharides and global responses in the era of vaccinomics.

Authors:  Antonio Cassone
Journal:  Pathog Glob Health       Date:  2013-09       Impact factor: 2.894

Review 2.  Thriving within the host: Candida spp. interactions with phagocytic cells.

Authors:  Pedro Miramón; Lydia Kasper; Bernhard Hube
Journal:  Med Microbiol Immunol       Date:  2013-01-25       Impact factor: 3.402

Review 3.  The Expanding Landscape of Moonlighting Proteins in Yeasts.

Authors:  Carlos Gancedo; Carmen-Lisset Flores; Juana M Gancedo
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

Review 4.  Development of vaccines for Candida albicans: fighting a skilled transformer.

Authors:  Antonio Cassone
Journal:  Nat Rev Microbiol       Date:  2013-12       Impact factor: 60.633

5.  Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.

Authors:  Charles V Rosadini; Sanjay Ram; Brian J Akerley
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

6.  Expression profiles of glyceraldehyde-3-phosphate dehydrogenase from Clonorchis sinensis: a glycolytic enzyme with plasminogen binding capacity.

Authors:  Yue Hu; Erhong Zhang; Lisi Huang; Wenfang Li; Pei Liang; Xiaoyun Wang; Jin Xu; Yan Huang; Xinbing Yu
Journal:  Parasitol Res       Date:  2014-10-10       Impact factor: 2.289

7.  Candida albicans Shaving to Profile Human Serum Proteins on Hyphal Surface.

Authors:  Elvira Marín; Claudia M Parra-Giraldo; Carolina Hernández-Haro; María L Hernáez; César Nombela; Lucía Monteoliva; Concha Gil
Journal:  Front Microbiol       Date:  2015-12-08       Impact factor: 5.640

Review 8.  Molecular basis of host specificity in human pathogenic bacteria.

Authors:  Xiaolei Pan; Yang Yang; Jing-Ren Zhang
Journal:  Emerg Microbes Infect       Date:  2014-03-26       Impact factor: 7.163

9.  Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin.

Authors:  Crisanto M Lopez; Reinhard Wallich; Kristian Riesbeck; Christine Skerka; Peter F Zipfel
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  A virtual infection model quantifies innate effector mechanisms and Candida albicans immune escape in human blood.

Authors:  Kerstin Hünniger; Teresa Lehnert; Kristin Bieber; Ronny Martin; Marc Thilo Figge; Oliver Kurzai
Journal:  PLoS Comput Biol       Date:  2014-02-20       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.